Advertisement
Screener

XTANT MEDICAL HOLDINGS, INC. (XTNT) Shareholder Equity

XTANT MEDICAL HOLDINGS, INC. (XTNT) Shareholder Equity

  • 2026-06-30: Additional Paid in CapitalUSD $307.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.00K; Retained Earnings (Accumulated Deficit)USD $-266.99M; Stockholders' Equity Attributable to ParentUSD $40.02M.
  • 2026-03-31: Additional Paid in CapitalUSD $306.18M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.00K; Retained Earnings (Accumulated Deficit)USD $-257.57M; Stockholders' Equity Attributable to ParentUSD $48.60M.
  • 2025-12-31: Additional Paid in CapitalUSD $305.44M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m); Retained Earnings (Accumulated Deficit)USD $-254.49M; Stockholders' Equity Attributable to ParentUSD $50.95M.
  • 2025-09-30: Additional Paid in CapitalUSD $304.79M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $139.00K; Retained Earnings (Accumulated Deficit)USD $-254.54M; Stockholders' Equity Attributable to ParentUSD $50.38M.

XTANT MEDICAL HOLDINGS, INC. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endAdditional Paid in Capital
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Other
USD
Preferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital, Common Stock
USD
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
USD
Treasury Stock, Value, Acquired, Cost Method
USD
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs
USD
2026-06-30$307.00M$-1.00K$-266.99M$40.02M3 month · $875.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2026-03-31$306.18M$-1.00K$-257.57M$48.60M3 month · $746.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-12-31$305.44M(m)$-254.49M$50.95M12 month · $2.89M12 month · $-65.00K(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30$304.79M$139.00K$-254.54M$50.38M3 month · $641.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-06-30$304.20M$152.00K$-255.85M$48.50M3 month · $766.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31$303.49M$-209.00K$-259.40M$43.88M3 month · $758.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-12-31$302.74M$-316.00K$-259.46M$42.96M12 month · $4.12M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30$301.97M$54.00K$-256.30M$45.73M3 month · $1.14M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30$296.45M$-175.00K$-251.27M$45.01M3 month · $1.23M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31$295.22M$-133.00K$-247.41M$47.68M3 month · $910.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$294.33M$29.00K$-243.01M$51.35M12 month · $2.74M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30$293.53M$-146.00K$-238.71M$54.68M3 month · $745.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30$278.90M(m)$-247.94M$30.96M3 month · $439.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31$278.46M(m)$-245.75M$32.71M3 month · $617.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31$277.84M(m)$-243.67M$34.17M12 month · $2.46M(m)(m)(m)(m)(m)(m)(m)12 month · $1.63M(m)
2022-09-30$274.23M(m)$-241.46M$32.77M3 month · $641.00K(m)(m)(m)(m)(m)(m)(m)3 month · $1.12M(m)
2022-06-30$267.25M(m)$-239.11M$28.14M3 month · $571.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31$266.68M(m)$-237.40M$29.28M3 month · $613.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$266.07M(m)$-235.19M$30.88M12 month · $2.21M(m)(m)(m)(m)(m)(m)(m)12 month · $5.24M(m)
2021-09-30$265.54M(m)$-232.90M$32.64M3 month · $580.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$264.98M(m)$-231.10M$33.88M3 month · $465.00K(m)$0.00$0.00(m)(m)(m)(m)(m)(m)
2021-03-31$263.73M(m)$-230.37M$33.37M3 month · $456.00K(m)(m)(m)(m)(m)(m)(m)3 month · $5.24M(m)
2020-12-31$244.85M(m)$-230.34M$14.51M12 month · $1.08M(m)$0.00$0.00(m)(m)(m)(m)12 month · $1.86M(m)
2020-09-30$181.65M(m)$-229.63M$47.98M3 month · $237.00K
9 month · $726.00K
(m)(m)(m)(m)(m)(m)(m)9 month · $1.86M(m)
2020-06-30$181.41M(m)$-228.27M$-46.86M3 month · $220.00K
6 month · $489.00K
(m)(m)(m)(m)(m)(m)(m)3 month · $1.86M
6 month · $1.86M
(m)
2020-03-31$179.33M(m)$-225.81M$-46.48M3 month · $269.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$179.06M(m)$-223.27M$-44.20M12 month · $515.00K(m)(m)(m)(m)(m)(m)(m)12 month · $9.00K(m)
2019-09-30(m)(m)$-221.66M$-42.86M3 month · $95.00K
9 month · $256.00K
(m)(m)(m)$178.80M(m)(m)(m)9 month · $9.00K(m)
2019-06-30(m)(m)$-219.78M$-41.08M3 month · $39.00K
6 month · $161.00K
(m)(m)(m)$178.71M(m)(m)(m)6 month · $9.00K(m)
2019-03-31(m)(m)$-217.84M$-39.18M3 month · $122.00K(m)(m)(m)$178.67M(m)(m)(m)3 month · $9.00K(m)
2018-12-31$171.27M(m)$-215.04M$-43.77M12 month · $814.00K(m)(m)(m)$171.27M(m)(m)(m)12 month · $5.11M12 month · $556.00K
2018-09-30(m)(m)$-158.35M$12.65M(m)(m)(m)(m)$171.01M(m)(m)(m)3 month · $5.11M
9 month · $5.11M
9 month · $556.00K
2018-06-30(m)(m)$155.20M$10.61M(m)(m)(m)(m)$165.81M(m)(m)(m)(m)6 month · $556.00K
2018-03-31(m)(m)$-150.20M$15.61M(m)(m)$0.00$0.00$165.81M(m)(m)(m)(m)3 month · $556.00K
2017-12-31(m)(m)$-144.95M$-58.70M(m)(m)$0.00$0.00$86.25M(m)(m)(m)(m)12 month · $480.00K
2017-09-30(m)(m)$-116.53M$-30.23M(m)(m)$0.00$18.00$86.30M(m)(m)(m)(m)9 month · $480.00K
2017-06-30(m)(m)$-108.01M$-21.91M(m)(m)$0.00$18.00$86.10M(m)(m)(m)(m)6 month · $480.00K
2017-03-31(m)(m)$-98.32M$-12.29M(m)(m)$0.00$18.00$86.03M(m)(m)(m)(m)3 month · $480.00K
2016-12-31(m)(m)$-92.53M$-7.07M(m)(m)$0.00$1.00$85.46M(m)(m)(m)(m)12 month · $0.00
2016-09-30(m)(m)$-88.00M$-5.10M(m)(m)$0.00$11.00$82.90M(m)(m)(m)(m)9 month · $0.00
2016-06-30(m)(m)$-83.10M$-496.34K(m)(m)(m)$11.00$82.60M(m)(m)(m)(m)(m)
2016-03-31(m)(m)$-78.64M$3.36M(m)(m)$0.00$11.00$82.00M(m)(m)(m)(m)(m)
2015-12-31(m)(m)$-73.04M$8.88M(m)(m)$0.00$11.00$81.92M(m)(m)(m)(m)12 month · $14.93M
2015-09-30(m)(m)$-84.63M$-2.83M(m)(m)$0.00$11.00$81.80M(m)(m)(m)(m)9 month · $14.93M
2015-06-30(m)(m)$-77.94M$-11.85M(m)(m)$0.00$7.00$66.09M(m)(m)(m)(m)(m)
2015-03-31(m)(m)$-75.04M$-10.47M(m)(m)$0.00$7.00$64.57M(m)(m)(m)(m)(m)
2014-12-31(m)(m)$-70.87M$-7.77M(m)(m)$0.00$7.00$63.09M(m)(m)(m)(m)12 month · $0.00
2014-09-30(m)(m)$-67.57M$-4.46M(m)(m)(m)$7.00$63.11M(m)(m)(m)(m)9 month · $0.00
2014-08-06(m)(m)(m)(m)(m)(m)(m)$1.46M(m)(m)(m)(m)(m)(m)
2014-06-30(m)(m)$-66.40M$-7.96M(m)(m)(m)$6.00$58.44M(m)(m)(m)(m)(m)
2014-03-31(m)(m)$-64.50M$-6.57M(m)(m)$0.00$55.00$57.93M(m)(m)(m)(m)(m)
2013-12-31(m)(m)$-60.36M$-3.84M(m)(m)$0.00$5.00$56.52M(m)(m)(m)(m)12 month · $1.49M
2013-09-30(m)(m)$-56.19M$-636.05K(m)(m)$0.00$52.00$55.56M(m)(m)(m)(m)(m)
2013-06-30(m)(m)$-51.82M$3.44M(m)(m)$0.00$52.00$55.25M(m)(m)(m)(m)(m)
2013-03-31(m)(m)$-49.33M$2.66M(m)(m)$0.00$43.00$51.99M(m)(m)(m)(m)(m)
2012-12-31(m)(m)$-47.67M$4.23M(m)(m)$0.00$43.00$51.90M(m)(m)12 month · $563.36K12 month · $563.36K(m)
2012-09-30(m)(m)$-42.79M$8.59M(m)(m)$0.00$43.00$51.38M(m)(m)(m)(m)(m)
2012-06-30(m)(m)$-40.27M$10.14M(m)(m)$0.00$43.00$50.41M(m)(m)(m)(m)(m)
2012-03-31$49.98M(m)$-41.00M$8.99M(m)(m)(m)$43.00(m)(m)(m)(m)(m)(m)
2011-12-31$45.45M(m)$-39.95M$5.50M(m)(m)$0.00$40.00$45.45M12 month · $227.39K(m)(m)(m)(m)
2011-09-30$44.28M(m)$-35.60M$8.69M(m)(m)(m)$40.00(m)(m)(m)(m)(m)(m)
2011-06-30$41.40M(m)$-32.43M$8.97M(m)(m)(m)$38.00(m)(m)(m)(m)(m)(m)
2010-12-31$36.33M(m)$-36.95M$-619.24K(m)12 month · $-595.15K(m)$37.00(m)12 month · $100.31K12 month · $135.47K(m)12 month · $405.00K(m)
2009-12-31(m)(m)(m)$4.68M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spectral AI, Inc. (MDAI)United States$0.052B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
InspireMD, Inc. (NSPR)$0.033B
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
PAVmed Inc. (PAVM)United States$0.031B-3.00